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PCOSAbstract Background: Dietary glycotoxins and androgen excess have been independently associ-
ated with a negative inﬂuence on the kidney. There are no data concerning the additive effects of
these two factors on the kidney function and structure, in females. The present study aims to inves-
tigate the effect of dietary glycotoxins and androgen excess on the kidneys of an androgenized
female rat model.
Methods: The study involved 80 female Wistar rats divided into 3 groups. The animals from group
A were androgenized at 4 weeks of age (n= 30), rats of group B were androgenized at 12–20 weeks
of age (n= 20) and group C consisted of non-androgenized animals (n= 30). All groups were fur-
ther randomly assigned, either to a high-Advanced Glycation End product diet (HA diet) or low-
AGE diet (LA diet), for 3 months.
Results: The rats fed with HA diet had signiﬁcantly higher serum creatinine levels (p 6 0.0002),
when compared with those fed with LA diet. The androgenized group fed with HA diet exhibited
higher levels of serum AGE (p= 0.0005), creatinine levels (p< 0.0001) and C-reactive protein
(CRP) levels (p 6 0.002), when compared with the non-androgenized group fed with HA diet.
AGE immunoreactivity was higher on the renal tubules of the androgenized animals fed with
HA diet, when compared with the animals fed with LA diet, but did not signiﬁcantly differ among
the two groups.‘Sotiria’
160 S. Palimeri et al.Conclusions: The above mentioned data suggest that dietary glycotoxins, in combination with
increased androgen exposure, exert a more profound negative impact on the kidney of an androg-
enized female rat model that mimics the metabolic characteristics of polycystic ovary syndrome.
ª 2015 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
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nd/4.0/).1. Introduction
Advanced glycation end products (AGEs) are a heterogeneous
group of compounds, formed from nonenzymatic reaction of
reducing sugars with proteins, lipids and nucleic acids.1 They
may induce many structural and vascular changes in several
tissues because of insoluble cross-link formation, induction
of oxidative stress (OS) and subsequent cell activation.2
Systemic AGEs are derived via either endogenous forma-
tion or exogenous food ingestion. Endogenous AGEs are
spontaneously produced in human tissues and in circulation
as part of normal metabolism and accumulate during normal
ageing. The process is accelerated in conditions of hypergly-
caemia and enhanced OS and has been implicated in the pro-
gression of age-related diseases such as diabetes mellitus,
atherosclerosis, chronic renal failure and Alzheimer’s disease.3
Exogenous derived AGEs are absorbed from sources such
as tobacco4 and Westernized diets, since thermally processed
common foods have high glycotoxin content.5 Evidence of
the last decade, generated from data in humans and experi-
mental animals, supports the contribution of exogenous
food-ingested AGEs to elevated serum levels and increased tis-
sue deposition.6,7
Excessive AGEs deposition may contribute to tissue injury
by at least two mechanisms. The ﬁrst is the receptor-
independent modiﬁcation of the protein structure, leading to
the cross-linking of matrix proteins8, the decreased catalytic
activity of enzymes9, the occurrence of epitopes with new
immunological properties10, or the decreased clearance of
lipoproteins.11 DNA damage may be caused via induction of
strand breaks, punctual mutations, the occurrence of a basic
sites, or depurination.12 Secondly, AGEs interact directly with
their speciﬁc receptors, of which the receptor for AGEs
(RAGE) is of pathogenic importance.13
Expression of RAGE is rapidly enhanced in tissues where
AGEs accumulate.14 The AGE–RAGE interaction mediates
pro-atherogenic, inﬂammatory and immune responses via acti-
vation of nuclear factor-jB (NF-jB). This activation leads to
increased expression/synthesis of cytokines, chemokines,
growth factors, adhesion molecules and reactive oxygen spe-
cies (ROS) production.15,13
The predominant removal of AGEs takes place in the kid-
ney. The important role of the kidneys in the metabolism and
excretion of endogenous and dietary AGEs has been demon-
strated in animals and humans with severe renal disease.16–18
The ﬁltered AGEs are partially degraded in the tubular system
of the kidney, while the rest are excreted with urine.19 The
proximal tubule has been identiﬁed as the site of catabolism
of AGE proteins and peptides both in vivo and in vitro20,
but almost all renal structures (basement membranes, mesan-
gial and endothelial cells, podocytes and tubules) are suscepti-
ble to AGE accumulation.11,21 AGEs are independentlyrelated to a decrease in the glomerular ﬁltration rate
(GFR)22, making them a possible class of uremic toxins.23
Besides AGEs, it is already known that testosterone may
play a crucial role in the acceleration of the tubular apoptotic
process and the progression of chronic kidney disease in males.
Testosterone is known to be proﬁbrotic, leading to mesangial
expansion and renal dysfunction.24
Moreover, the positive correlation between AGE and
androgens has been demonstrated in young normoglycemic
women with polycystic ovary syndrome (PCOS), which pre-
sented with high AGE levels compared to a group of ovulatory
normoandrogenic women. Interestingly, in this study the corre-
lation between AGE proteins and testosterone levels remained
high controlling for body mass index (BMI), insulin levels and
area under curve of glucose (AUCGLU), implying an interac-
tion between AGE proteins and hyperandrogenemia.25
Considering the above mentioned data, the aim of the pre-
sent study was to analyse the effect of dietary glycotoxins and
androgen excess on the kidneys of an androgenized female rat
model, which simulates the reproductive and metabolic envi-
ronment of women with hyperandrogenemic syndromes, such
as PCOS.
2. Materials and methods
2.1. Study population
The study involved 80 female Wistar rats, which were divided
into 3 main groups: Group A consisted of 30 rats, aged
4 weeks, which at 4 weeks of age were androgenized by subcu-
taneous implantation of 90-d continuous release pellets con-
taining 7.5 mg dihydrotestosterone (DHT), leading to a daily
exposure of 83 lg DHT. The above mentioned process previ-
ously presented by Manneras et al.26 This experimental model
was selected to mimic both the reproductive and metabolic
characteristics of PCOS women, who have 1.7-fold increase
in DHT levels, than those of normal women.27,28 Group A
was subsequently randomly divided into two subgroups based
on food content; Subgroup A1 (n= 15, baseline body
weight = 99.7 ± 2.7 g) was fed commercial chow with low
AGE content, for 3 months, while subgroup A2 (n= 15, base-
line body weight = 94.7 ± 2.6 g) was fed commercial chow
with high content in AGE, for 3 months.
Group B included 20 older rats, aged 12–20 weeks, which
were also androgenized with the same way as previously
described. Similarly, a further random division into two sub-
groups, based on the criteria of AGE content, followed andro-
genization. Subgroup B1 (n= 10, baseline body weight =
190.5 ± 5.5 g) was fed commercial chow with low in AGE
content for 3 months, while subgroup B2 (n= 10, baseline
body weight = 184.0 ± 8.2 g) was exposed to a HA diet, for
3 months.
Additive effects of dietary glycotoxins and androgen excess 161Finally, group C included 30 nonandrogenized animals,
which at 12–20 weeks of age, were equally subdivided into
two groups. Subgroup C1 (n= 15, baseline body
weight = 197.0 ± 4.3 g) followed a LA diet for 3 months,
while subgroup C2 (n= 15, baseline body weight = 199.7 ±
4.2 g) was fed commercial chow with high in AGE content
for 3 months.7
The animals were housed four to ﬁve per cage under con-
trolled conditions (21–22 C, 55–65% humidity, 12-h
light/12-h dark cycle) and were given pelleted food and water
ad libitum at ELPEN (Experimental Research Centre,
Athens, Greece). Animal care and experimental procedures
conformed to the ‘‘Guide for the Care and Use of
Laboratory Animals’’ (Department of Health, Education and
Welfare, Athens, Greece). This study was approved by the
Institutional Animal Care and Use Committee.
Body weight was monitored weekly. The study was con-
cluded after 3 months, and rats were sacriﬁced, after a 12 h
fasting. Initially, the animals were subjected to anaesthesia
with ether, allowing blood sample collection after puncture
of the tail vein. The whole blood was collected in a covered test
tube and allowed to clot at room temperature for 30 min.
Then, the clot was removed by centrifugation at 2500 rpm
for 15 min, in a refrigerated centrifuge. Following centrifuga-
tion the serum was immediately transferred into 0.5 ml ali-
quots, transported and stored at 80 C.29
The parameters measured from rat serum were: AGE
(U/mL) levels in order to study the effect of dietary glycotoxins
on the circulating AGE levels7,16,18, creatinine (mg/dL) and
CRP (lg/mL) levels in order to study the effect of dietary gly-
cotoxins on the kidney function and the possible provocation
of inﬂammatory process.13,24,42 In addition, testosterone
(ng/mL) levels were measured in order to study the effect of
dietary glycotoxins on the hormonal status and particularly
on testosterone levels, since testosterone has been implicated
in kidney damage.40,41 Finally, insulin (lU/mL) and glucose
(mg/dL) levels were measured in order to investigate the effect
of dietary glycotoxins on the metabolism.7
Subsequently, the animals were sacriﬁced with administra-
tion of 20 mg/mL xylazine hydrochloride (dose 100 mg/kg)
and 100 mg/mL ketamine hydrochloride (dose 10 mg/kg), at
a dose rate 0.2 ml/100 g body weight, by intraperitoneal injec-
tion, allowing kidney tissue retrieval. The kidney was removed
immediately and placed in 10% formalin in phosphate-
buffered saline (PBS), pH 7.4, for 18 h before parafﬁn
embedding.302.2. Diets
The diets used were derived from a single standard rat chow
(AIN-93G) purchased from Bioserve (Frenchtown, NJ,
USA), consisting of 18% protein, 58% carbohydrate, 7.5%
fat, and 3.73 kcal/g. Regular AIN-93G chow is normally pre-
pared by heating at 190 C for 30 min. Analysis of this prepa-
ration was performed as previously described.7
The HA diet contained 76.0 ± 15.3 mg CML/100 g sample
(or 436.9 ± 88.1 mg CML/100 g protein), 205.32 ± 22.25 mg
fructoselysine/100 g sample (or 1.179.98 ± 127.90 mg fruc-
toselysine/100 g protein) and 52.68 ± 5.71 mg furosine/100 g
sample (or 302.78 ± 32.82 mg furosine/100 g protein) and
was considered as a HA diet.The same rodent mix was also prepared without heating.
This preparation was of equivalent macro- and micronutrient
and energy content but contained 1.3 ± 0.4 mg CML/100 g
sample (or 7.7 ± 2.2 mg CML/100 g protein), 104.58 ±
3.08 mg fructoselysine/100 g sample (or 601.01 ± 17.7 mg
fructoselysine/100 g protein) and 26.83 ± 0.79 mg furosine/
100 g sample (or 154.22 ± 4.54 mg furosine/100 g protein)
and was considered an LA diet.
2.3. Biochemical and hormonal assays
Testosterone was measured by enzyme-linked immunosorbent
assay (ELISA) using commercially available kits (Calbiotech,
CA, USA). Insulin was also quantiﬁed using ELISAs pur-
chased by Biovendor Laboratory Medicine (Brno, Czech
Republic) and Neogen Corporation (Lexington, KY, USA),
respectively. Serum AGE levels (U/mL) were measured by
CML-speciﬁc competitive ELISA, as described previously.
Biochemical assays (serum creatinine, glucose and CRP levels)
were performed in the chemical analysis system ADVIA 1200
(Siemens, Healthcare Diagnostics, NY, USA), using commer-
cially available kits (Bayer AG, Athens, Greece).
2.4. Immunohistochemical analysis
Parafﬁn-embedded sections of formalin-ﬁxed kidney tissue
were deparafﬁnized by xylene and dehydrated in graded etha-
nol. Sections were treated in 3% hydrogen peroxide in phos-
phate buffered saline (PBS) for 15 min and then rinsed in
PBS. To increase the immunoreactivity of AGEs, the sections
were placed in 500 mL of 0.01 mol/L citric acid-buffered solu-
tion (pH 7.0) and microwaved at 500 W for 5 min. After thor-
ough washing, the sections were incubated with normal rabbit
serum for 20 min at room temperature to avoid nonspeciﬁc
binding of the antibodies. The sections were then incubated
overnight at 4 C with the anti-AGE monoclonal antibody
6D12 (0.25 mg/Ml stock, dilution 1:50; Research
Diagnostics, Concord, MA, USA) in PBS containing 1%
bovine serum albumin. Immunoreactivity was detected by
the streptavidin–biotin–peroxidase method according to the
manufacturer’s protocol. The ﬁnal reaction product was visu-
alized with 3,30-diaminobenzidine tetrahydrochloride (LSAB
detection kit; Dako, Carpentaria, CA, USA). Lung tissue sec-
tions from diabetic rats were used as positive controls for AGE
antibody. Negative controls (for example, kidney tissue in
which the primary antibody was substituted with nonimmune
mouse or goat serum) were also stained in each run. The per-
centage of positive cells was estimated using light microscopy.
The evaluation of the immunostained slides was performed
blindly and independently by two observers. AGE immunore-
activity was expressed in terms of H-score, i.e. the percentage
of positive cells multiplied by the intensity of staining.31
2.5. Statistical methods
Descriptive statistics were calculated for the examined param-
eters (body weight at baseline, body weight at 3 months,
AGEs, serum testosterone, insulin, CRP, serum glucose, crea-
tinine, AGEs H-scores in the glomeruli, proximal and distal
convoluted tubules, collecting ducts); values are presented as
mean ± standard error of the mean (SE).
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162 S. Palimeri et al.Given the deviation from normality, veriﬁed by the
Shapiro–Wilk test, non-parametric statistical tests were per-
formed. Speciﬁcally, the overall heterogeneity between the six
study groups was evaluated by the Kruskal–Wallis test.
Seven meaningful pairwise comparisons were a priori con-
structed in the study design, namely: A1 vs. A2, B1 vs. B2,
C1 vs. C2 (to assess the high vs. low AGEs comparison), as
well as A1 vs. B1, A2 vs. B2 (aiming to evaluate the effect of
age at androgenization), B1 vs. C1, B2 vs. C2 groups (to
examine the effects of androgenization per se); all pairwise
comparisons were assessed by the Mann–Whitney–Wilcoxon
test for independent samples. The level of statistical
signiﬁcance regarding the seven pairwise comparisons was set
at 0.05/7 = 0.007 (Bonferroni correction for multiple
comparisons) as appropriate, whereas the level of statistical
signiﬁcance regarding the overall heterogeneity remained at
the 0.05 level, given that multiple comparisons did not pertain
to the latter overall notion. Finally, the intercorrelations
between study variables were examined by means of the
Spearman’s rank correlation coefﬁcient. Statistical analysis
was performed with STATA/SE version 13 (Stata Corp.,
College Station, TX, USA).
3. Results
3.1. Comparisons evaluating the effect of AGEs
The descriptive statistics regarding body weight, measured
serum parameters and AGEs immunostaining are presented
in Table 1. Signiﬁcant between-groups heterogeneity was noted
concerning the majority of examined parameters, except for
serum glucose.
Overall, AGE immunoreactivity was mainly conﬁned to the
tubules, the glomerular tufts being positive on only 11 cases.
Since the expression of AGEs in the epithelial cells was similar
in the distal tubules and collecting ducts, this was analysed as a
single parameter.
Compared with group A1, group A2 exhibited higher
AGEs levels (as expected, p< 0.0001), lower body weight at
3 months (p= 0.0001), higher serum testosterone
(p= 0.0004), higher serum insulin (p= 0.0001), CRP
(p< 0.0001) and creatinine (p< 0.0001) (Figs. 1 and 2).
AGE immunoreactivity on the proximal and distal convoluted
tubules was increased in A2 animals (Fig. 3) but did not reach
statistical signiﬁcance among the two groups (p= 0.1578,
p= 0.1483 respectively).
Compared with group B1, group B2 presented with higher
AGEs levels (p= 0.0002), higher serum testosterone levels
(p= 0.0002) and creatinine (p= 0.0002) (Figs. 1 and 2). B2
animals exhibited higher but not statistically signiﬁcant AGE
immunoexpression in the glomerular tuft and collecting ducts
or distal convoluted tubules (Fig. 3) (p= 0.9395 and
p= 0.3118 respectively).
Regarding the group C2 vs. C1 comparison, higher AGEs
levels were observed in the serum (p< 0.0001) as well as in
the proximal convoluted tubules (p= 0.055, Figs. 3 and 4) fol-
lowed by elevated serum testosterone (p< 0.0001), insulin
(p< 0.0001) and CRP (p< 0.0001) in C2 group compared
to C1 (Figs. 1 and 2).
Figure 1 Effect of HA-diet and androgen exposure on creatinine
levels. The prepubertal androgenized rats (A2) and adult andro-
genized rats (B2) on a HA-diet, exhibit higher serum creatinine
levels, than the respective groups of rats on a LA-diet (A1 and B1).
The non-androgenized group does not present any statistically
signiﬁcant difference (C1 and C2).
Figure 2 Effect of androgen exposure on CRP levels. The adult
androgenized animals (B1 and B2) exhibited higher CRP levels
when they were compared with the age-matched adult non-
androgenized animals (C1 and C2), either fed with HA- or LA-
diet.
Additive effects of dietary glycotoxins and androgen excess 1633.2. Comparisons pertaining to the effect of age at
androgenization and androgenization per se
Table 2 presents the results of the a priori designed compar-
isons between the study groups pertaining to the effects of
age at androgenization (left panels) and to the effect of andro-
genization per se (right panels).
With respect to the effects of age at androgenization,
Groups A1 and A2 presented with signiﬁcantly lower body
weight at baseline than groups B1 and B2, respectively(p< 0.0001 for both comparisons), but no differences in body
weight were noted at three months. Lower CRP (p< 0.0001)
levels were noted in group A1 vs. group B1, but this pattern
was not reproducible upon the A2 vs. B2 comparison.
With respect to the effect of androgenization per se, groups
C1 and C2 presented with signiﬁcantly lower weight at three
months than groups B1 and B2 (p= 0.0008 and p= 0.005,
respectively), although the respective differences were not sig-
niﬁcant at baseline. Group B2 exhibited higher levels of serum
AGEs (p= 0.0005), testosterone (p= 0.002), and creatinine
(p< 0.0001) than group C2, whereas these differences were
not observed in the C1 vs. B1 comparison. CRP levels in
groups B1/B2 were consistently higher than the respective
levels in groups C1/C2 (p< 0.0001 and p= 0.002). No consis-
tent differences were noted regarding AGEs immunohisto-
chemical indices.
3.3. Intercorrelations between study parameters
Table 3 presents the results pertaining to the intercorrelations
between study parameters. A network of strong associations
was noted, implicating higher serum testosterone, creatinine,
CRP, AGEs in the serum, as well as AGEs immunostaining
in tubules, which were all closely associated with each other
in the study population. Nevertheless, this table should be
deemed explorative in view of the numerous correlations tested
simultaneously and cross-sectionally, a fact that per se does
not allow the establishment of causality.
4. Discussion
It has been previously demonstrated that AGEs are metabo-
lized and removed by the kidney,19,28,32, but the kidney is also
a site for accumulation of AGEs and AGE-related damage.33
Therefore, the kidney is affected by AGEs, and declining renal
function entails an increase in serum AGE levels, amplifying
the damage from them.13 Furthermore, dietary intake of glyco-
toxins contributes to a substantial portion of circulating AGE
level18, and dietary restriction of glycotoxins has been shown
to reduce serum AGE levels in patients with renal failure.34
In agreement with the above mentioned data, the present
study demonstrated that a diet high in AGE content may neg-
atively affect the renal biochemistry and morphology. In more
details, the animal groups fed with a HA diet had signiﬁcantly
higher serum creatinine levels, when they were compared with
those fed with a LA diet. The effect of HA diet on the kidney
was also shown through AGE immunohistochemistry. Higher
AGE expression was observed in the epithelial cells of
proximal and distal convoluted tubules of androgenized ani-
mals without however reaching statistical signiﬁcance, while
in the nonandrogenized group signiﬁcant AGE immunoreac-
tivity was observed in the proximal tubules of high AGE fed
animals.
The kidney is known to play an important role in the meta-
bolism of AGEs. The present data are in agreement with pre-
vious studies suggesting that almost all renal structures are
susceptible to the accumulation of AGEs including basement
membranes, mesangial and endothelial cells, podocytes and
tubules.35,36 Vlassara et al., demonstrated that chronic admin-
istration of in vitro-prepared protein-AGEs to otherwise
healthy rats could lead to advanced pathological changes in
Figure 3 Expression of AGEs in epithelial cells of proximal convoluted tubules. The group of rats fed with HA-diet [(A2) represents the
prepubertal androgenized rats, (B2) the androgenized rats and (C2) the adult non-androgenized rats, fed with HA-diet] [exhibit higher
AGE immunoreactivity than the respective animals fed with LA-diet [(A1) represents the prepubertal androgenized rats, (B1) the adult
androgenized rats and (C1) the adult non-androgenized rats, fed with LA-diet]. Magniﬁcation ·100.
Figure 4 Box plot illustrating the higher AGEs immunoreactiv-
ity in C2 group when compared to C1 group (p= 0.0055) in
epithelial cells of proximal convoluted tubules.
164 S. Palimeri et al.renal glomerular structure and function.37 Moreover, the prox-
imal tubule has been identiﬁed as the site of catabolism of
AGE proteins and peptides both in vivo and in vitro.20 In
addition, as described by Gu et al., AGE-modiﬁed bovine
serum albumin (BSA) induced upregulation of monocyte
chemoattractant protein-1 (MCP-1) expression in podocytes
through activation of RAGE and generation of intracellular
ROS.38 In human renal biopsies, AGE-accumulation is pri-
marily found in renal basement membranes in diabetic and
non-diabetic nephropathy, and its accumulation involves
upregulation of RAGE in podocytes.39 All the above
information, offers conﬁrmatory evidence for a cause and
effect relationship between long-term AGE accumulation
and renal pathology.Interestingly, the only group that did not present any statis-
tically signiﬁcant difference in the serum creatinine levels was
the one that was not subjected to the androgenization process
(Fig. 1). This ﬁnding may suggest that the interplay of the high
dietary intake of AGEs with the high androgen exposure may
contribute to a more profound kidney injury. Trying to clarify
this hypothesis, we extended our data analysis in order to eval-
uate the effect of androgenization on renal biochemistry and
structure. Therefore, the adult androgenized group fed with
HA diet exhibited higher levels of serum AGE and creatinine
levels, when compared with the non-androgenized group fed
with HA diet, while in the respective groups fed with LA diet
there were no statistically signiﬁcant differences. These data
imply the cumulative aggravating effect of exogenously derived
AGEs and androgen excess on kidney function.
Indeed, it has been shown that the sexual dimorphism is
deeply reﬂected on renal morphology and physiology, most
likely due to the actions of gonadal steroids and to the
endocrine/paracrine pathways of the kidney. Testosterone is
known to be proﬁbrotic since it stimulates extracellular
matrix proteins (EMP) deposition in glomerular mesangial
cells (GMCs), leading to mesangial expansion and renal
dysfunction.40
Moreover, Pawluczyk et al. have shown that male rat
mesangial cells express higher baseline ﬁbronectin mRNA,
tumor necrosis factor-a (TNF-a) and interleukin-1b levels than
female rat mesangial cells, indicating the potential proinﬂam-
matory and proﬁbrotic actions of testosterone in the kidney.24
Additionally, androgens have been shown to increase
proapoptotic signalling.41 Furthermore, glomerular sclerosis
is known to occur faster and more intensely in males than in
females.40 Taken together, these data indicate that testosterone
may play a crucial role in the acceleration of the tubular apop-
totic process and the progression of chronic kidney disease in
males.
Table 2 Detailed list of the a priori designed comparisons between the study groups pertaining to the effects of age at androgenization
or androgenization per se. Bold cells denote statistically signiﬁcant differences. §Derived from Mann–Whitney–Wilcoxon test for
independent samples (Level of statistical signiﬁcance: <0.007 due to the Bonferroni correction).
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adult androgenized animals exhibited higher CRP levels, when
they were compared with the age matched adult nonandroge-
nized animals. Moreover, the CRP levels were positively corre-
lated with serum creatinine and AGE levels and with AGE
deposition in the kidney. These data imply, that either andro-
gen excess per se, or via its deteriorating effect on renal func-
tion and structure, creates an inﬂammatory environment for
the kidney. Consistent with this view are older studies that
have described chronic kidney disease as a ‘‘micro-
inﬂammatory state’’42, with a high prevalence of acute phase
inﬂammation and OS, both of which are associated with a high
rate of cardiovascular morbidity and mortality.43–45 On the
other hand, the proinﬂammatory and proﬁbrotic actions of
testosterone on the kidney have been indicated by in vitro
studies, which have demonstrated that basal tumor necrosis
factor-a (TNF-a) and interleukin-1b levels are higher in male
mesangial cells compared to female mesangial cells. This sexualdimorphism in mesangial cells may play a role in the faster
progression of glomerulosclerosis leading to end-stage renal
disease in males.41
This study has several limitations. Although, the sample
size of the analysed groups was satisfactory, some differences
did not reach statistical signiﬁcance. Additionally, determina-
tion of serum creatinine level consists of a simple and reliable
method for the control of renal function. Nevertheless, more
accurate methods, such as creatinine clearance or glomerular
ﬁltration ratio, should be estimated. Finally, the androgenized
animals exhibited higher body weights when compared with
the non-androgenized age matched animals. It would be useful
to analyse the body composition by dual-emission X-ray
absorptiometry (DEXA), in order to determine the body fat
and lean body mass.
In conclusion, while the studies upon male subjects, con-
cerning the androgen effect on the kidney, vary, females with
hyperandrogenemic syndromes (such as PCOS), lack evidence
Table 3 Intercorrelations between study parameters. Spearman’s rho values with respective p-values in brackets are presented.
Correlations with p-values < 0.05 have been highlighted in bold.
166 S. Palimeri et al.on the effect of hyperandrogenemia on the female kidney. This
is the ﬁrst study to our knowledge, which analysed the possible
synergistic effects of exogenously derived glycotoxins and
androgen excess on renal biochemistry and morphology. The
study included a female rat model that exerts the metabolic
and hormonal characteristics of women with hyperandrogene-
mia. In summary, the present study suggests that dietary glyco-
toxins, in combination with increased androgen exposure,
exert a more profound negative impact on the kidney of an
androgenized female rat model that mimics female hyperan-
drogenemic syndromes, such as PCOS. Moreover, dietaryglycotoxins and androgen excess induce an inﬂammatory envi-
ronment for the kidney, which could further aggravate its
structure and function. However, further studies are necessary
to elucidate the mechanisms via which androgens augment the
detrimental effect of exogenously derived AGEs on the female
kidney.
Conﬂict of interest
The authors stated that there are no conﬂict of interests
regarding the publication of this article.
Additive effects of dietary glycotoxins and androgen excess 167References
1. Niwa T. Mass spectrometry for the study of protein glycation in
disease. Mass Spectrom Rev 2006;25:713–23.
2. Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of
advanced glycation end products contribute to the aging pheno-
type? J Gerontol A Biol Sci Med Sci 2010;65:963–75.
3. Goh SY, Cooper ME. Clinical review: the role of advanced
glycation end products in progression and complications of
diabetes. J Clin Endocrinol Metab 2008;93:1143–52.
4. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D,
Vanpatten S, et al. Tobacco smoke is a source of toxic
reactive glycation products. Proc Natl Acad Sci USA 1997;94:
13915–20.
5. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J,
et al. Advanced glycoxidation end products in commonly con-
sumed foods. J Am Diet Assoc 2004;104:1287–91.
6. de Assis AM, Rieger DK, Longoni A, Battu C, Raymundi S, da
Rocha RF, et al. High fat and highly thermolyzed fat diets
promote insulin resistance and increase DNA damage in rats. Exp
Biol Med (Maywood) 2009;234:1296–304.
7. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki
G, Levidou G, Papalois A, et al. Accumulation of dietary
glycotoxins in the reproductive system of normal female rats. J
Mol Med 2007;85:1413–20.
8. Avery NC, Bailey AJ. The effects of the Maillard reaction on the
physical properties and cell interactions of collagen. Pathol Biol
(Paris) 2006;54:387–95.
9. Sˇebekova K, Schinzel R, Ling H, Simm A, Xiang G, Gekle M,
et al. Advanced glycated albumin impairs protein degradation in
the kidney proximal tubular cell line LLC-PK1. Cell Mol Biol
1998;44:1051–60.
10. Lubeck G, Pollak A. Reduced susceptibility of non-enzymatically
glycosylated glomerular basement membrane to proteinases. Renal
Physiol 1980;3:4–8.
11. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A,
et al. Modiﬁcation of low-density lipoprotein by advanced glyca-
tion end products contributes to the dyslipidemia of diabetes and
renal insufﬁciency. Proc Natl Acad Sci USA 1994;91:9441–5.
12. Stopper H, Schupp N, Klassen A, Sebekova K, Heidland A.
Genomic damage in chronic renal failure – potential therapeutic
interventions. J Ren Nutr 2005;15:81–6.
13. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation
end products and the kidney. Am J Physiol Renal Physiol
2005;289:F645–59.
14. Suzuki D, Toyoda M, Yamamoto N, Miyauchi M, Katoh M,
Kimura M, et al. Relationship between the expression of
advanced glycation end-products (AGE) and the receptor for
AGE (RAGE) mRNA in diabetic nephropathy. Intern Med
2006;45:435–41.
15. Bierhaus A, Stern DM, Nawroth PP. RAGE in inﬂammation:
a new therapeutic target? Curr Opin Investig Drugs 2006;7:
985–91.
16. Vlassara H. Advanced glycation in health and disease. Role of
modern environment. Ann NY Acad Sci 2005;1043:452–60.
17. Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C,
et al. Orally absorbed reactive glycation products (glycotoxins):
an environmental risk factor in diabetic nephropathy. Proc Natl
Acad Sci USA 1997;94:6474–9.
18. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, et al.
Dietary glycotoxins correlate with circulating advanced glycation
end product levels in renal failure patients. Am J Kidney Dis
2003;42:532–8.
19. Gugliucci A, Bendayan M. Renal fate of circulating advanced
glycation end products (AGEs): evidence for absorption and
catabolism of AGE-peptides by renal proximal tubular cells.
Diabetologia 1996;39:149–60.20. Saito A, Takeda T, Sato K, Hama H, Tanuma A, Kaseda R, et al.
Signiﬁcance of proximal tubular metabolism of advanced glyca-
tion end products in kidney diseases. Ann NY Acad Sci
2005;1043:637–43.
21. Jensen LJ, Ostergaard J, Flyvbjerg A. AGE–RAGE and AGE
cross-link interaction: important players in the pathogenesis of
diabetic kidney disease. Horm Metab Res 2005;37(suppl 1):26–34.
22. Semba RD, Ferrucci L, Fink JC, Sun K, Beck J, Dalal M, et al.
Advanced glycation end products and their circulating receptors
and level of kidney function in older community-dwelling women.
Am J Kidney Dis 2009;53:51–8.
23. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O,
Massy Z. Emerging biomarkers for evaluating cardiovascular
risk in the chronic kidney disease patient: how do new pieces
ﬁt into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:
505–21.
24. Pawluczyk IZ, Tan EK, Harris KP. Rat mesangial cells exhibit
sex-speciﬁc proﬁbrotic and proinﬂammatory phenotypes. Nephrol
Dial Transplant 2009;24:1753–8.
25. Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G.
Increased levels of serum advanced glycation end-products in
women with polycystic ovary syndrome. Clin Endocrinol (Oxf)
2005;62:37–43.
26. Mannera˚s L, Cajander S, Holma¨ng A, Seleskovic Z, Lystig T,
Lo¨nn M, et al. A new rat model exhibiting both ovarian and
metabolic characteristics of polycystic ovary syndrome.
Endocrinology 2007;148:3781–91.
27. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt
W. Beyond adrenal and ovarian androgen generation: increased
peripheral 5a-reductase activity in women with polycystic ovary
syndrome. J Clin Endocrinol Metab 2003;88:2760–6.
28. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin
M, et al. Early endocrine, metabolic, and sonographic character-
istics of polycystic ovary syndrome (PCOS): comparison between
nonobese and obese adolescents. J Clin Endocrinol Metab
2003;88:4682–8.
29. Henry JB. Clinical Diagnosis and Management by Laboratory
Methods, vol. 1. Philadelphia: W.B Saunders Company; 1979.
30. Wolfensohn S, Lloyd M. Handbook of Laboratory Animal
Management and Welfare. Oxford: Oxford University Press;
1994.
31. van Diest PJ, van Dam P, Henzen-Logmans SC, Berns E, van der
Burg ME, Green J, et al. A scoring system for immunohisto-
chemical staining: consensus report of the task force for basic
research of the EORTC-GCCG. European Organization for
Research and Treatment of Cancer-Gynaecological Cancer
Cooperative Group. J Clin Pathol 1997;50:801–4.
32. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, van Ypersele
de Strihou C, et al. Renal catabolism of AGEs: the fate of
pentosidine. Kidney Int 1998;53:416–22.
33. Schinzel R, Mu¨nch G, Heidland A, Sebekova K. Advanced
glycation end products in end-stage renal disease and their
removal. Nephron 2001;87:295–303.
34. Bostom A. Homocysteine: ‘‘expensive creatinine’’ or important
modiﬁable risk factor for arteriosclerotic outcomes in renal
transplant recipients? J Am Soc Nephrol 2000;11:149–51.
35. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of
the glycoxidation product N(epsilon)-(carboxymethyl)lysine
in human tissues in diabetes and aging. J Clin Invest 1997;99:
457–68.
36. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H,
et al. Immunohistochemical colocalization of glycoxidation prod-
ucts and lipid peroxidation products in diabetic renal glomerular
lesions. Implication for glycoxidative stress in the pathogenesis of
diabetic nephropathy. J Clin Invest 1997;100:2995–3004.
37. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M.
Advanced glycation end products induce glomerular sclerosis and
168 S. Palimeri et al.albuminuria in normal rats. Proc Natl Acad Sci USA 1994;
91:11704–8.
38. Gu L, Hagiwara S, Fan Q, Tanimoto M, Kobata M, Yamashita
M, et al. Role of receptor for advanced glycation end-products
and signaling events in advanced glycation end-product-induced
monocyte chemoattractant protein-1 expression in differentiated
mouse podocytes. Nephrol Dial Transplant 2006;21:299–313.
39. Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A,
Pischetsrieder M, et al. Expression of advanced glycation end
products and their cellular receptor RAGE in diabetic nephropa-
thy and nondiabetic renal disease. J Am Soc Nephrol
2000;11:1656–66.
40. Lombet JR, Adler SG, Anderson PS, Nast CC, Olsen DR,
Glassock RJ. Sex vulnerability in the subtotal nephrectomy model
of glomerulosclerosis in the rat. J Lab Clin Med 1989;114:66–74.41. Metcalfe PD, Leslie JA, Campbell MT, Meldrum DR, Hile KL,
Meldrum KK. Testosterone exacerbates obstructive renal injury
by stimulating TNF-alpha production and increasing proapop-
totic and proﬁbrotic signaling. Am J Physiol Endocrinol Metab
2008;294:E435–43.
42. Kaysen GA. The microinﬂammatory state in uremia: causes and
potential consequences. J Am Soc Nephrol 2001;12:1549–57.
43. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant
in uremia: oxidant stress as a unifying concept of cardiovascular
disease in uremia. Kidney Int 2002;62:1524–38.
44. Arici M, Walls J. End-stage renal disease, atherosclerosis, and
cardiovascular mortality: Is C-reactive protein the missing link?
Kidney Int 2001;59:407–14.
45. Stenvinkel P. Inﬂammatory and atherosclerotic interactions in the
depleted uremic patient. Blood Purif 2001;10:53–61.
